Table 1

Patients’ characteristics and medical treatment

Case 1Case 2Case 3Case 4
LAD, left anterior descending artery; RCA, right coronary artery; rt-PA, recombinant tissue type plasminogen activator; TIMI, thrombolysis in myocardial infarction.
Age (years)47364435
Risk factors
    Familial historyNoNoNoNo
    DiabetesType INoNoNo
History of other disease(s)NoNoHeterozygous for prothrombin G20210A gene polymorphismVaricose veins in the left leg
Leads with ST elevation at ECG on admissionV1–V5V2–V6V4–V6, DI, aVLDII, DIII, aVF
Site of culprit lesionMid-LADProximal LADProximal LADMid-RCA
Angiographic features of infarct related artery
    TIMI flow2233
    Thrombus score3223
Antithrombotic treatment
    Acetylsalicylic acid (500 mg bolus intravenously followed by 250 mg/day orally)YesYesYesYes
    rt-PA (before angiography)YesYesNoNo
    Abciximab (bolus 0.25 mg/kg intravenously plus 12 hours infusion 0.125 mg/kg/min intravenously)YesYesYesYes
    Unfractionated heparin (infusion for 48 hours followed by low molecular weight heparin subcutaneously for 15 days)YesYesYesYes
    Clopidogrel (loading dose of 300 mg orally followed by 75 mg/day orally)YesYesYesYes